Recruiting Retinitis Pigmentosa Studies in Miami
Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)
To evaluate the long-term safety and tolerability of oral dersimelagon....
A Phase 3 Study Of OCU400 Gene Therapy for the Treatment Of Retinitis Pigmentosa
This is a Phase 3 study to Assess the Efficacy, Safety and Tolerability of OCU400 in patients with retinitis pigmentosa (RP) associated with RHO mutations and patients with any other RP associated mut...
Study of Bitopertin in Participants With EPP or XLP (APOLLO)
The goal of this clinical trial is to learn if bitopertin works and is safe to treat EPP or XLP in participants 12 years or older. The main questions it aims to answer are: * Whether bitopertin incre...
A Study to Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor Disease (CLARICO)
Study OpCT-001-101 is a Phase 1/2a first-in-human, multisite, 2-part interventional study to evaluate the safety, tolerability, and the effect on clinical outcomes of OpCT-001 in up to approximately 5...
Promising ROd-cone DYstrophy Gene therapY
This is a two-step, multicenter, Phase I/II study including an open-label dose-escalation phase (Step 1) and a three-arm, controlled, double-masked, randomized extension phase (Step 2), in subjects wi...
A Phase 2 Open-label Study to Evaluate the Safety of Laruparetigene Zovaparvovec Administered Bilaterally in Male Participants With X-Linked Retinitis Pigmentosa
The purpose of this Phase 2 Study is to see if the investigational study drug, laruparetigene zovaparvovec, also known as AGTC-501, given in both eyes, is safe and works to preserve and/or improve vis...
About Retinitis Pigmentosa Clinical Trials in Miami
Retinitis pigmentosa (RP) is a group of inherited retinal diseases that cause progressive loss of photoreceptor cells in the retina, leading to vision loss. It typically begins with night blindness and progresses to tunnel vision. Gene therapy and retinal implants are areas of active research.
There are currently 6 retinitis pigmentosa clinical trials recruiting participants in Miami, FLORIDA. These studies are seeking a combined 698 participants. Research is being sponsored by Mitsubishi Tanabe Pharma America Inc., Ocugen, Disc Medicine, Inc and 3 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Retinitis Pigmentosa Clinical Trials in Miami — FAQ
Are there retinitis pigmentosa clinical trials in Miami?
Yes, there are 6 retinitis pigmentosa clinical trials currently recruiting in Miami, FLORIDA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Miami?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Miami research site will contact you about next steps.
Are clinical trials in Miami free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Miami studies also compensate for your time and travel.
What retinitis pigmentosa treatments are being tested?
The 6 active trials in Miami are testing new therapies including novel drugs, biologics, and treatment approaches for retinitis pigmentosa.
Data updated March 2, 2026 from ClinicalTrials.gov